I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A Retrospective Study of First-Line Therapy Involving Immun..:
Hyunji Jo
;
Joohyun Hong
;
Hongsik Kim
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.874385/full. , 2022
Link:
https://doi.org/10.3389/fonc.2022.874385
RT Journal T1
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d54aa331e55345cfab3849aa5aec1ee0&Exemplar=1&LAN=DE A1 Hyunji Jo A1 Joohyun Hong A1 Hongsik Kim A1 Hye Ryeon Kim A1 Ghee Young Kwon A1 Kyung A. Kang A1 Sung Yoon Park A1 Chan Kyo Kim A1 Byung Kwan Park A1 Jae Hoon Chung A1 Wan Song A1 Minyong Kang A1 Hyun Hwan Sung A1 Hwang Gyun Jeon A1 Byong Chang Jeong A1 Seong Il Seo A1 Seong Soo Jeon A1 Hyun Moo Lee A1 Se Hoon Park PB Frontiers Media S.A. YR 2022 K1 immunotherapy K1 immune checkpoint inhibitors K1 renal cell carcinoma K1 IMDC poor-risk K1 overall survival K1 sunitinib K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.874385/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.874385 DO https://doi.org/10.3389/fonc.2022.874385 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)